Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-29

FDA Approved: TOBRAMYCIN INHALATION — Supplemental Application (Prasco, LLC)

View source ↗

Summary

FDA approved a supplemental application for Tobramycin Inhalation submitted by Prasco, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBRAMYCIN INHALATION (TOBRAMYCIN)

Snippet

SUPPL AP for TOBRAMYCIN INHALATION (TOBRAMYCIN INHALATION)